Package 68788-6328-3

{"route": ["ORAL"], "spl_id": "e287efc6-2c34-4d2f-b8e0-f59f3f93c99e", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897659"], "spl_set_id": ["d23c757d-39f8-48c3-ba63-df2cbe58c516"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-3)", "package_ndc": "68788-6328-3", "marketing_start_date": "20161017"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-6)", "package_ndc": "68788-6328-6", "marketing_start_date": "20210928"}], "brand_name": "verapamil hydrochloride", "product_id": "68788-6328_e287efc6-2c34-4d2f-b8e0-f59f3f93c99e", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68788-6328", "generic_name": "verapamil hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA090700", "marketing_category": "ANDA", "marketing_start_date": "20161017", "listing_expiration_date": "20261231"}